Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.
Research Interests

Papers共 40 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Efficacy and Clinical Outcomes of Crizotinib in Patients with ROS1-Rearranged NSCLC: A Multicenter Study
Alper Topal,Goncagul Akdag,Sedat Yildirim,Oguzcan Kinikoglu,Deniz Isik, Gizem Yildirim,Salih Tunbekici, Fatih Kus, Aydın Acarbay, Murad Guliyev, Nargiz Majidova, Yasin Kutlu,Mustafa Erman,Hatice Odabas,Nedim Turan,Nuri Karadurmus
Medicina (Kaunas, Lithuania)no. 3 (2025)
Cited0Views0WOSBibtex
0
0
Comparison of Paclitaxel and Docetaxel in Dual HER2 Blockade: Efficacy and Safety in Neoadjuvant Treatment of HER2-positive Breast Cancer
Ezgi Turkoglu, Goncagul Akdag Topal,Sedat Yildirim,Oguzcan Kinikoglu, Nisanur Sariyar Busery, Miray Aydogan, Hacer Sahika Yildiz, Seval Orman, Ayberk Bayramgil, Tugce Kubra Gunes, Mustafa Alperen Tunc, Nargiz Majidova,Deniz Isik, Sermin Kokten,Hatice Odabas,Nedim Turan
Breast Cancer Research and Treatmentno. 3 (2025): 743-752
Cited0Views0WOSBibtex
0
0
Real-life Data on Adjuvant Trastuzumab Emtansine Treatment in Early-Stage HER2-positive Breast Cancer: a Turkish Oncology Group Study
Selin Akturk Esen,Ismet Seven, Gonca Akdere Ates, Rumeysa Colak,Oğuzcan Kinikoglu, Busra Akay Hacan, Yasemin Bakkal Temi, Nadiye Sever,Seda Kahraman, Haci Arak,Atakan Topcu, Seray Saray, Sinem Akbas, İsmail Beypinar, Omer Acar, Atike Pinar Erdoğan,Mesut Yilmaz,Deniz Isik,Ozturk Ates,Devrim Cabuk,Mehmet Ali Nahit Sendur,Dogan Uncu
Anti-cancer drugs (2025)
Cited0Views0WOSBibtex
0
0
The Association of Khorana Risk Score with Venous Thromboembolism and Overall Survival in Patients with Metastatic Gastric Cancer
Ezgi Turkoglu, Goncagul Akdag Topal,Sedat Yıldırım,Oguzcan Kınıkoglu, Nisanur Sarıyar Busery, Tugba Kaya, Hacer Sahika Yıldız, Furkan Turkoglu, Cihad Tatar,Abdullah Sakin,Deniz Isık, Seval Ay Ersoy, Tugba Basoglu,Hatice Odabas,Nedim Turan
Medicinano. 6 (2025): 1075
Cited0Views0Bibtex
0
0
Tumor-infiltrating Lymphocytes As Predictive Biomarkers in Neoadjuvant Treatment of HER2-positive Breast Cancer
Oğuzcan Kınıkoğlu, Yunus Emre Altıntaş, Anıl Yıldız, Goncagül Akdağ, Hamit Bal, Zeynep Yüksel Yaşar, Uğur Özkerim, Hacer Şahika Yıldız, Sıla Öksüz, Salih Tünbekici,Akif Doğan,Deniz Işık,Alper Yaşar, Tuğba Başoğlu,Heves Sürmeli,Hatice Odabaş,Nedim Turan
The oncologistno. 4 (2025)
Cited0Views0WOSBibtex
0
0
The Impact of Carboplatin on Pathologic Complete Response and Survival Based on HER2 Low and HER2 Zero Status in Triple Negative Breast Cancer Patients Receiving Neoadjuvant Chemotherapy: a Multicenter Real-World Analysis
Sedat Yıldırım, Tugba Başoğlu,Akif Doğan, Goncagul Akdağ,Oguzcan Kınıkoğlu,Alper Topal,Ozkan Alan, Ali Alper Solmaz,Mustafa Gürbüz,Timucin Çil, Rumeysa Çolak,Mesut Yılmaz, Ali Kalem, Nadiye Sever, Nargiz Majıdova, Kubilay Karakoyun, Serhat Sekmek, Omer Saçlı,Melike Ozcelık,Deniz Işık,Heves Surmeli, Ozlem Nuray Sever,Hatice Odabas, Mahmut Emre Yıldırım,Nedim Turan
BMC Cancerno. 1 (2025): 1-12
Cited0Views0WOSBibtex
0
0
Very Favorable Vs. Favorable Risk Groups in Metastatic Renal Cell Carcinoma: A Step Toward Personalized Treatment
Yunus Emre Altıntaş,Oğuzcan Kınıkoğlu,Deniz Işık, Tuğçe Kübra Güneş, Uğur Özkerim, Tuğba Basoglu,Heves Sürmeli,Hatice Odabaş,Nedim Turan
Cancersno. 7 (2025)
Cited0Views0WOSBibtex
0
0
Load More
Author Statistics

#Papers: 39

#Citation: 81

H-Index: 6

G-Index: 8

Sociability: 6

Diversity: 1

Activity: 20

  • 合作者
  • 学生
  • 导师
No result temporarily, you can search similar Scholar with the same research interest
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn